Introduction:Basic information about CAS 1438492-26-2|ciraparantag, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | ciraparantag |
|---|
| CAS Number | 1438492-26-2 | Molecular Weight | 512.69600 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C22H48N12O2 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | di-arginine piperazine |
|---|
| Synonym | More Synonyms |
|---|
ciraparantag BiologicalActivity
| Description | Ciraparantag is a thrombin and factor Xa inhibitors as well as to heparin-based anticoagulants through non-covalent hydrogen bonding and charge interactions. It is reported to antagonize the effects of all coagulants except VKAs and agratroban. [1][2] |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Cardiovascular Disease |
|---|
| References | [1]. Arundhati Das et al. Novel antidotes for target specific oral anticoagulants. Exp Hematol Oncol, 2015, 4: 25. [2]. Tiffany Y Hu et al. Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab. Vasc Health Risk Manag, 2016, 12: 35-44. |
|---|
Chemical & Physical Properties
| Molecular Formula | C22H48N12O2 |
|---|
| Molecular Weight | 512.69600 |
|---|
| Exact Mass | 512.40200 |
|---|
| PSA | 240.52000 |
|---|
| LogP | 1.23780 |
|---|
| InChIKey | HRDUUSCYRPOMSO-ROUUACIJSA-N |
|---|
| SMILES | NC(N)=NCCCC(N)C(=O)NCCCN1CCN(CCCNC(=O)C(N)CCCN=C(N)N)CC1 |
|---|
| Storage condition | 2-8℃ |
|---|
Synonyms
| 2-amino-5-guanidino-pentanoic acid (3'-{4-[3-(2-amino-5-guanidino-pentanoylamino)-propyl]-piperazin-1-yl}-propyl)-amide |
| ciraparantag |
| (2S,2'S)-N,N'-(1,4-Piperazinediyldi-3,1-propanediyl)bis[2-amino-5-[(aminoiminomethyl)amino]pentanamide] |
| PER977 |